A Case for Transperineal Biopsies
May 21, 2020
Prostate Biopsy Standards Although prostate cancer is the most commonly diagnosed cancer in men, the optimal method for diagnosis remains unclear. Favoured for its convenience
Menu
patient care
Standard biopsies blindly sample 1% of the prostate. We're here to set a new standard of care with MRI-targeted fusion biopsies.
Prostate cancer will affect 1 in 7 men. 1
The standards for screening and biopsy blindly sample the prostate without knowing where the cancer is, if any. We're here to set a new standard of care with MRI-targeted fusion biopsies.
The mission to improve
Focal Healthcare is a world-class medical device company, dedicated to improving the physician and patient experience from prostate cancer diagnosis to treatment.
diagnostics
Standard biopsies blindly sample 1% of the prostate. We're here to set a new standard of care with MRI-targeted fusion biopsies.
Prostate cancer will affect 1 in 7 men. 1
The standards for screening and biopsy blindly sample the prostate without knowing where the cancer is, if any. We're here to set a new standard of care with MRI-targeted fusion biopsies.
The mission to improve
Focal Healthcare is a world-class medical device company, dedicated to improving the physician and patient experience from prostate cancer diagnosis to treatment.
patient outcomes
Standard biopsies blindly sample 1% of the prostate. We're here to set a new standard of care with MRI-targeted fusion biopsies.
Prostate cancer will affect 1 in 7 men. 1
The standards for screening and biopsy blindly sample the prostate without knowing where the cancer is, if any. We're here to set a new standard of care with MRI-targeted fusion biopsies.
The mission to improve
Focal Healthcare is a world-class medical device company dedicated to improving the physician and patient experience from prostate cancer diagnosis to treatment.
Together we are stronger...
Working with a multi-disciplinary team of engineers, designers, developers, urologists, radiologists and patients, we gain a diverse range of perspectives and turn those into meaningful insights. Taking the best of both worlds, we combine ultrasound with MRI and quality materials with user-centered design to create innovative imaging tools that simplify targeted biopsies and therapy.
A few guiding principles
Good design starts with form and function. Great design embodies the principles upon which it is built. Informed by our end users, our products are designed around three key pillars:
Accuracy
Reliably targets lesions using MRI-ultrasound fusion
Compared to ultrasound imaging, MRI can be considered the “Gold Standard” for detecting lesions. MRI-targeted biopsies with Fusion Bx lead to increased cancer detection rates by addressing 3 key sources of inaccuracy: prostate deformation, patient motion and registration.
Efficiency
Simplified workflow minimizes training and procedural times
Innovative technology doesn’t need to be complicated. Driven by end users, our 4-step guided workflow and semi-robotic arm eases the procedure for both physicians and patients.
Accessibility
Cost effective and easy to use fusion biopsy solution
Through rigorous testing and a fine attention to detail, we’ve developed a quality cost effective solution for fusion biopsies. Thoughtful engineering, multi-probe compatibility and accommodating customer service makes our system accurate, efficient and accessible to everyone.
Introducing the Fusion Bx
The Fusion Bx’s semi-robotic arm allows the probe to be maneuvered effortlessly, while maintaining consistent pressure on the prostate. With a freehand-like motion and minimal prostate deformation, the Fusion Bx enables you to accurately locate and target suspicious regions of interest.
Play Video
Fusion 101
Fusion biopsy technology combines previously taken MRIs with live ultrasound to improve the visibility of suspicious lesions in the prostate. This allows physicians to take fewer cores because lesions can now be targeted. Get to know more about fusion and the Fusion Bx.
For Physicians
Fusion Bx strikes the optimal balance between accuracy and efficiency.
Learn more >
For Patients
Fusion Bx provides meaningful and actionable results with less biopsies.
Learn more >
Let us tell you more
Email us for more information and we’ll start the conversation.
How I Do It -MRI-ultrasound fusion prostate biopsy using the Fusion MR and Fusion Bx systems
April 28, 2020
Check out this month’s Canadian Journal of Urology “How I Do It” section featuring Focal Healthcare’s Fusion Bx presented by Nathan Perlis, MD, Bishoy Lawendy,
Transrectal vs. Transperineal Approach for Prostate Biopsy
April 22, 2020
Standards for Prostate Biopsy Prostate cancer is the most commonly diagnosed cancer amongst men. It is estimated that over 2 million biopsies are performed annually.1
1 Statistics – Prostate Cancer Canada. (n.d.). Retrieved from prostatecancer.ca
2 Cookson, M. S., MD, & Stratton, K. L., MD. (2018, April 10). Point: Is MRI fusion biopsy the new gold standard for diagnosis?Urology Times. Retrieved from urologytimes.com